04:14 AM EDT, 09/02/2025 (MT Newswires) -- Qiagen ( QGEN ) said Tuesday its QIAstat-Dx Rise syndromic testing system has received clearance from the US Food and Drug Administration and is set for US market entry.
The system is available in more than 100 countries, the company said.